netFormulary Northern Lincolnshire NHS
Formulary  
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
Notes:

Blood Glucose Testing Strip Guidance

 Details...
06.01.02.03  Expand sub section  Other antidiabetic drugs
06.01.02.03  Expand sub section  Alpha glucosidase inhibitors
06.01.02.03  Expand sub section  DPP4 inhibitors (gliptins)
Alogliptin (Vipidia▼®)
View adult BNF View SPC online View childrens BNF  Track Changes 		First Choice
Green

Tablet

 
   
Linagliptin (Trajenta▼®)
(DPP4 inhibitor)
View adult BNF View SPC online View childrens BNF  Track Changes 		First Choice
Green

DPP-4 inhibitor approved for use in patients with severe renal or hepatic impairment

 
Link  MHRA Alert: Dipeptidylpeptidase-4 inhibitors: risk of acute pancreatitis
   
Sitagliptin (Januvia®)
(DPP4 inhibitor)
View adult BNF View SPC online View childrens BNF  Track Changes 		Second Choice
Green

Tablet

 
Link  MHRA Alert: Dipeptidylpeptidase-4 inhibitors: risk of acute pancreatitis
   
Saxagliptin (Onglyza®)
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Green

Tablet

 
   
06.01.02.03  Expand sub section  GLP1 agonists
06.01.02.03  Expand sub section  Meglitinides to top
06.01.02.03  Expand sub section  SGL2 inhibitors
06.01.02.03  Expand sub section  Thiazolidinediones
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
SMC
 Scottish Medicines Consortium
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Green

 Green -Medicines suitable for routine use within primary care and Secondary care Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies  

Amber

 Amber- Medicines suitable to be prescribed in primary care after specialist /Consultant recommendation or initiation. A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust Medicines and Therapeutic Committee and approved by the Area Prescribing Committee.   

Red

 Red-Hospital initiation and continuation only  

Amber Shared Care Protocol

 AMBER SHARE CARE PROTOCOL- Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised  

Blue

 To be supplied from the appropriate commissioned provider.   

Green 2

 GREEN 2- to be prescribed by primary care only   

Grey

 GREY- NON FORMULARY (As agreed by Area Prescribing Committee)  

netFormulary